Literature DB >> 15708921

Psoriasis clinical registries, genetics, and genomics.

James T Elder1.   

Abstract

Genetics and genomics are being widely applied in an effort to unlock the secrets of psoriasis. At the same time, an explosion of exciting new biological therapies has brought large numbers of patients into clinical trials. Opportunities exist for synergism between therapeutic trials and genetic/genomic studies of psoriasis (and psoriatic arthritis). This article reviews existing clinical registries of psoriasis, with an emphasis on genetic studies; compares and contrasts the types of information necessary for genetic, genomic, and clinical registries; and considers the impact of patient privacy on the use of registries for both clinical and genetic studies.

Entities:  

Mesh:

Year:  2005        PMID: 15708921      PMCID: PMC1766870          DOI: 10.1136/ard.2004.030833

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

Review 1.  Patterns of genetic variation in Mendelian and complex traits.

Authors:  M E Zwick; D J Cutler; A Chakravarti
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

2.  Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population.

Authors:  Gurdeep S Sagoo; Rachid Tazi-Ahnini; Jonathan W N Barker; James T Elder; Rajan P Nair; Lena Samuelsson; Heiko Traupe; Richard C Trembath; Darren A Robinson; Mark M Iles
Journal:  J Invest Dermatol       Date:  2004-06       Impact factor: 8.551

Review 3.  Searching for the major histocompatibility complex psoriasis susceptibility gene.

Authors:  Francesca Capon; Margo Munro; Jonathan Barker; Richard Trembath
Journal:  J Invest Dermatol       Date:  2002-05       Impact factor: 8.551

4.  Psoriasis, its treatment, and cancer in a cohort of Finnish patients.

Authors:  A Hannuksela-Svahn; E Pukkala; E Läärä; K Poikolainen; J Karvonen
Journal:  J Invest Dermatol       Date:  2000-03       Impact factor: 8.551

Review 5.  Searching for genetic determinants in the new millennium.

Authors:  N J Risch
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

6.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.

Authors:  Xianghong Zhou; James G Krueger; Ming-Chih J Kao; Ed Lee; Fenghe Du; Alan Menter; Wing Hung Wong; Anne M Bowcock
Journal:  Physiol Genomics       Date:  2003-03-18       Impact factor: 3.107

7.  Disease concomitance in psoriasis.

Authors:  T Henseler; E Christophers
Journal:  J Am Acad Dermatol       Date:  1995-06       Impact factor: 11.527

8.  Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution.

Authors:  F Brandrup; N Holm; N Grunnet; K Henningsen; H E Hansen
Journal:  Acta Derm Venereol       Date:  1982       Impact factor: 4.437

9.  Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

Authors:  Carle F Paul; Vincent C Ho; Claire McGeown; Enno Christophers; Birgit Schmidtmann; Jean-Claude Guillaume; Véronique Lamarque; Louis Dubertret
Journal:  J Invest Dermatol       Date:  2003-02       Impact factor: 8.551

10.  A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.

Authors:  Cynthia Helms; Li Cao; James G Krueger; Ellen M Wijsman; Francesca Chamian; Derek Gordon; Michael Heffernan; Jil A Wright Daw; Jason Robarge; Jurg Ott; Pui-Yan Kwok; Alan Menter; Anne M Bowcock
Journal:  Nat Genet       Date:  2003-11-09       Impact factor: 38.330

View more
  3 in total

1.  Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: a meta-analysis.

Authors:  Min Qi; Xiaoyuan Huang; Lei Zhou; Jianglin Zhang
Journal:  DNA Cell Biol       Date:  2014-04       Impact factor: 3.311

Review 2.  Psoriasis assessment tools in clinical trials.

Authors:  S R Feldman; G G Krueger
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

3.  Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene.

Authors:  Tuba Bozduman; Sibel Ersoy Evans; Sevilay Karahan; Yildiz Hayran; Filiz Akbiyik; Incilay Lay
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.